CVM (CEL-SCI Corp) Net earnings per share growth this year
CEL-SCI Corporation conducts its development within a stable US legal framework, which minimizes operational risks. Annual EPS variation reflects current dynamics, where the 0.00 mark records this metric. This figure is influenced by prolonged immunotherapy trials and patent dependency, as well as global conflicts, which often slow down the operations of research centers and complicate the export of new drugs.
Analytical breakdowns and data insights for company CEL-SCI Corporation (CVM)
- stock value and consensus price forecast:
- business market valuation indicators:
- company book value details:
- debt burden and liquidity indicators:
- company profitability and valuation multiples indicators:
CVM - Net Profit|Future Profit CEL-SCI Corporation|CVM - Price to Earnings Ratio|Projected Price to Earnings Ratio CEL-SCI Corp|CVM - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation CEL-SCI Corporation|CVM - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months CEL-SCI|CVM - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months cel-sci.com|CVM - Earnings per share growth in current year|Expected earnings per share trend next year CEL-SCI Corporation
- revenue and sales proceeds data:
Fundamental valuation:CVM, CEL-SCI Corporation
Investors are seeking a fundamental anchor in assets characterized by high uncertainty. The CEL-SCI Corporation (CVM) model is based on capital-intensive R&D developments in the absence of current sales. The 12-month earnings per share (EPS) growth rate measures the dynamics of net income per share relative to the previous year. This indicator captures the rate at which the company's cash reserves are depleting, allowing for an objective assessment of the asset's impairment risk.
Direct competitors
Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|OSTX - Earnings per share growth rate in current year|Radiopharm Theranostics - Net earnings per share growth this year|Earnings per share increase in current year ARTV|ANL - Earnings per share growth in current year|VERU - Earnings growth in current year|Tempest Therapeutics, Inc. (TPST) - Earnings per share growth in current year|XLO: Net earnings per one share growth for the current year|RENB (Renovaro Biosciences) - Earnings growth in current year|MURA: Earnings per share increase in current year|Net earnings per share growth this year KAPA (Kairos Pharma Ltd)|Net earnings per one share growth for the current year OKUR|CytoMed Therapeutics Limited - Net earnings per share growth this year|CRIS: Earnings per share growth this year|APLM - Earnings per share growth in current year|THAR - Earnings growth in current year|ADVB: Earnings growth in current year|Earnings per share growth this year GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Earnings growth in current year|Earnings per share growth in current year SBFM|Earnings growth in current year XBIO|Net earnings per share growth this year Salarius Pharmaceuticals SLRX|Earnings growth in current year PPBT (Purple Biotech Ltd)|AONC - Net earnings per share growth this year|BGNE: Net earnings per share growth this year|Expected net earnings per share growth this year Checkpoint Therapeutics, Inc CKPT|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD Inc. (ICAD)|IKNA (Ikena) - Earnings growth in current year|Net earnings per share growth this year Notable Labs (NTBL)|Earnings growth in current year VIRX|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma
